Stay informed about INVO news, programming and initiatives, as well as Northwestern headlines related to innovation and entrepreneurship. You can also engage with us on Twitter (@NUatINVO).
Lakeside Discovery supports two Northwestern labsScientists will lead multi-year projects to advance pharmaceuticals for muscular dystrophies and cancer. "We are excited that the two foundational projects for Lakeside Discovery reflect our commitment to advance Northwestern’s transformational innovations to the patient,” said Alicia Löffler, executive director of Northwestern’s Innovation and New Ventures Office. Read the article.
The Propel Program
Temprian Therapeutics accepted to S2STemprian Therapeutics will participate at the 2019 Science to Startup (S2S) symposium in Cambridge, Massachusetts. This invitation-only event on April 23 features twelve startups before an audience of 150+ pharmaceutical investors. Read more about Temprian Therapeutics.
The INVO newsletter, covering Northwestern's innovation and entrepreneurial activity across all disciplines, reaches the Northwestern University community, prospective licensees, investors, and others interested in groundbreaking research with commercialization potential.